Statistics
Publications
20
Citations
2.6K
H-Index
19
Active since
2010
Kimberley Stannard is an author at QIMR Berghofer Medical Research Institute specializing in oncology, cancer immunotherapy, and cancer immunology.
Publications per year
2010–2020
20
20
CIS is a potent checkpoint in NK cell–mediated tumor immunity
Rebecca B. Delconte, Tatiana B. Kolesnik, Laura F. Dagley et al. · Nature Immunology · 2016 · 387 citations
Life Sciences, Immunology, Oncology +13
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young, Shin Foong Ngiow, Yulong Gao et al. · Cancer Research · 2017 · 380 citations · Full text
Life Sciences, Immunology, Oncology +17
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma
Camille Guillerey, Heidi Harjunpää, Nadège Carrié et al. · Blood · 2018 · 297 citations · Full text
Life Sciences, Immunology, Oncology +16
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal, Arabella Young, Kimberley Stannard et al. · Cancer Research · 2014 · 239 citations
Medicine, Oncology, Pharmacology +16
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Stephen J. Blake, Kimberley Stannard, Jing Liu et al. · Cancer Discovery · 2016 · 231 citations
Life Sciences, Immunology, Oncology +17
1–5 of 20